Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 516

Results For "NAL"

5205 News Found

LupinLife to promote hand hygiene at Kumbh Mela 2021
News | March 24, 2021

LupinLife to promote hand hygiene at Kumbh Mela 2021

Lupin will provide five lakh LupiSafe hand sanitizers to policemen and frontline workers deployed at strategic locations


NPPA brings 80 plus medicines under price regulation
News | March 22, 2021

NPPA brings 80 plus medicines under price regulation

NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.


Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
News | March 18, 2021

Merck accelerates expansion plans for single-use products critical to manufacturing vaccines

The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.


Merck brings new renewable energy to the grid through VPPA with Enel Green Power
News | March 18, 2021

Merck brings new renewable energy to the grid through VPPA with Enel Green Power

Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power


LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants
News | March 17, 2021

LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants

Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.


Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO
News | March 15, 2021

Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO

The vaccine was 85 percent effective in preventing severe disease across all regions.


AstraZeneca Pharma India receives approval for supplying Osimertinib in India
News | March 13, 2021

AstraZeneca Pharma India receives approval for supplying Osimertinib in India

The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.


Lupin Pharma Canada announces Partnership with Endoceutics
News | March 09, 2021

Lupin Pharma Canada announces Partnership with Endoceutics

Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.


NATCO receives approval for Everolimus tablets for the US market
News | March 09, 2021

NATCO receives approval for Everolimus tablets for the US market

NATCO's partner BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks.


Vivimed Labs receives products approvals from Uzbekistan
News | March 09, 2021

Vivimed Labs receives products approvals from Uzbekistan

Vivimed strategy is to increase its share of Branded products in CIS Markets.